Delivery Order SPE2DE21D7001-SPE2D625F934W

Award Date 11/20/24
Potential Completion Date 11/21/24
Potential Value $10K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Spring Lake Park, MN 55432, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D7001
    Indefinite Delivery Contract
  • SPE2DE21D7001-SPE2D625F934W
    Delivery Order

This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Medtronic Inc., through its Medtronic USA, Inc. division. The contract is for the supply of BIOLOGICS - DBM-TS-MAGNIFUSE DBM, a medical device product. The contract has a ceiling value of $10,473.75 and is a fixed-price with economic price adjustment contract type. The contract does not have a set-aside designation. Medtronic Inc. is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies for various fields, including cardiovascular, neuromodulation, diabetes, and surgical technologies. The company has a significant Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs, valued at up to $600 million, for providing surgical implants and related products and services through December 2028.

Generated 2/19/25, 9:12 AM